España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Kiniksa Pharmaceuticals
KNSA
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$21.61
0
0.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Get Report
Watch
Kiniksa Pharmaceuticals (KNSA) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Kiniksa Pharmaceuticals (NASDAQ:KNSA) Stock
Kiniksa Pharmaceuticals Stock (NASDAQ: KNSA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, July 09, 2024
Kiniksa Pharmaceuticals Commences Enrollment ...
Benzinga Newsdesk
Monday, June 17, 2024
Kiniksa Pharmaceuticals Sponsors American Hea...
Benzinga Newsdesk
Friday, June 14, 2024
Kiniksa Pharmaceuticals - Expects Redomicilia...
Benzinga Newsdesk
Friday, May 03, 2024
Wells Fargo Initiates Coverage On Kiniksa Pha...
Benzinga Newsdesk
Wednesday, May 01, 2024
JP Morgan Maintains Overweight on Kiniksa Pha...
Benzinga Newsdesk
Wednesday, April 24, 2024
Evercore ISI Group Maintains Outperform on Ki...
Benzinga Newsdesk
Tuesday, April 23, 2024
Kiniksa Expects 2024 Arcalyst Net Product Rev...
Benzinga Newsdesk
Kiniksa Pharmaceuticals Q1 2024 GAAP EPS $(0....
Benzinga Newsdesk
Earnings Scheduled For April 23, 2024
Benzinga Insights
Wednesday, February 28, 2024
Kiniksa Expects 2024 ARCALYST Net Product Rev...
Benzinga Newsdesk
Kiniksa Pharmaceuticals Q4 EPS $0.35 Beats $(0.14) Estimate, Sales $83.39M Beat $72.02M Estimate
Happy Mohamed
Earnings Scheduled For February 28, 2024
Benzinga Insights
Tuesday, February 27, 2024
Earnings Outlook For Kiniksa Pharmaceuticals
Benzinga Insights
Thursday, January 04, 2024
Kiniksa Pharmaceuticals Says ARCALYST (rilona...
Benzinga Newsdesk
Tuesday, January 02, 2024
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Wedbush Maintains Outperform on Kiniksa Pharm...
Benzinga Newsdesk
Tuesday, October 31, 2023
Kiniksa Pharmaceuticals Q3 GAAP EPS $(0.20) V...
Benzinga Newsdesk
Earnings Scheduled For October 31, 2023
Benzinga Insights
Monday, October 30, 2023
Earnings Outlook For Kiniksa Pharmaceuticals
Benzinga Insights
Monday, September 11, 2023
5 Value Stocks In The Healthcare Sector
Benzinga Insights
Monday, August 21, 2023
5 Value Stocks To Watch In The Healthcare Sector
Benzinga Insights
Friday, July 28, 2023
Chief Medical Officer of Kiniksa Pharmaceuticals Makes $555K Sale
Benzinga Insights
Wednesday, July 26, 2023
Goldman Sachs Maintains Buy on Kiniksa Pharma...
Benzinga Newsdesk
Tuesday, July 25, 2023
Crude Oil Up 1%; Verizon Earnings Beat Views
Lisa Levin
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Kiniksa Pharmaceuticals shares are trading hi...
Benzinga Newsdesk
Xerox, Logitech International, Packaging Corporation of America And Other Big Stocks Moving Higher On Tuesday
Lisa Levin
UPDATE: Kiniksa Pharmaceuticals Q2 Adj EPS $(0.02) Beats $(0.17) Estimate, Sales $71.47M Beat $52.20M Estimate
Happy Mohamed
Kiniksa Forecasts Arcalyst Revenues Of $220M-...
Benzinga Newsdesk
Kiniksa Pharmaceuticals Q2 Adj EPS $(0.02) Be...
Benzinga Newsdesk
Earnings Scheduled For July 25, 2023
Benzinga Insights
Monday, July 24, 2023
Earnings Outlook For Kiniksa Pharmaceuticals
Benzinga Insights
5 Value Stocks In The Healthcare Sector
Benzinga Insights
Monday, June 05, 2023
Overview Of Value Stocks In The Healthcare Sector
Benzinga Insights
Monday, May 22, 2023
A Look Into Healthcare Sector Value Stocks
Benzinga Insights
Thursday, March 09, 2023
JP Morgan Maintains Overweight on Kiniksa Pha...
Benzinga Newsdesk
Tuesday, February 28, 2023
Kiniksa Pharmaceuticals Sees FY23 Net Product Revenue $190M-$205M Vs $239.17M Est
Happy Mohamed
Kiniksa Pharmaceuticals Q4 EPS $0.06 Beats $(0.23) Estimate, Sales $61.88M Beat $45.11M Estimate
Happy Mohamed
Earnings Scheduled For February 28, 2023
Benzinga Insights
Monday, January 09, 2023
5 Value Stocks In The Healthcare Sector
Benzinga Insights
Kiniksa Pharmaceuticals Reports Q4 ARCALYST N...
Benzinga Newsdesk
Wednesday, November 02, 2022
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
Lisa Levin
Gartner, Sony, Uber And Other Big Gainers From Tuesday
Lisa Levin
Tuesday, November 01, 2022
Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Kiniksa Pharmaceuticals shares are trading hi...
Benzinga Newsdesk
Recap: Kiniksa Pharmaceuticals Q3 Earnings
Benzinga Insights
Kiniksa Pharmaceuticals Q3 EPS $3.18 Up From ...
Benzinga Newsdesk
Monday, October 24, 2022
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Wednesday, August 03, 2022
Kiniksa Inks Global License Agreement With Roche For Vixarelimab
Vandana Singh
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch